Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A clinically heterogeneous progressive condition characterized by a combination of proximal neurogenic muscle weakness, sensory-motor neuropathy, ataxia, and pigmentary retinopathy.
Features include: Retinal pigment epithelial mottling, Seizure, Myopathy, and Global developmental delay and 10 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Seizure, Global developmental delay, Ataxia |
Eyes |
Estimated prevalence: 1-9 in 100,000 (Uncommon).
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
10 publications have been identified in PubMed for NARP syndrome. Research spans Basic Science / Preclinical (50%), Review / Meta-Analysis (20%), and Case Report / Case Series (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 5 | 50% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:00 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about NARP syndrome
4
Retinal pigment epithelial mottling, Nystagmus, Blindness |
Muscles | 4 | Myopathy, Mitochondrial myopathy, Proximal muscle weakness |
Research summaries |
2 |
20% |
Patient case studies | 2 | 20% |
New treatment approaches | 1 | 10% |
Pinho BR (2026). [PMID: 41587019](https://pubmed.ncbi.nlm.nih.gov/41587019/). *Pharmacol Rep*. [Basic Science / Preclinical]
Zakirova E (2026). [PMID: 42049921](https://pubmed.ncbi.nlm.nih.gov/42049921/). *Sci Rep*. [Gene Therapy / Novel Therapeutics]
Kiepper AL (2025). [PMID: 40257346](https://pubmed.ncbi.nlm.nih.gov/40257346/). *Pain Med Case Rep*. [Case Report / Case Series]
Karuntu JS (2025). [PMID: 39733931](https://pubmed.ncbi.nlm.nih.gov/39733931/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Yu M (2025). [PMID: 39940729](https://pubmed.ncbi.nlm.nih.gov/39940729/). *Int J Mol Sci*. [Review / Meta-Analysis]
Ito M (2025). [PMID: 40629055](https://pubmed.ncbi.nlm.nih.gov/40629055/). *Sci Rep*. [Basic Science / Preclinical]
Cham ED (2024). [PMID: 39194577](https://pubmed.ncbi.nlm.nih.gov/39194577/). *Biology (Basel)*. [Basic Science / Preclinical]
Sala D (2024). [PMID: 38755691](https://pubmed.ncbi.nlm.nih.gov/38755691/). *Orphanet J Rare Dis*. [Case Report / Case Series]
Haschke AM (2024). [PMID: 39270524](https://pubmed.ncbi.nlm.nih.gov/39270524/). *Stem Cell Res*. [Basic Science / Preclinical]
Ansari S (2024). [PMID: 39619320](https://pubmed.ncbi.nlm.nih.gov/39619320/). *Clin Case Rep*. [Basic Science / Preclinical]